ESTRO 2024 - Abstract Book

S2760

Interdisciplinary - Global health

ESTRO 2024

Income Classification

Cancer incidence

Cases benefitting

Utilisation Rates

PBT

RT

PBT

RT

LIC

468,067

30,736

229,660

6.57%

49.07%

LMIC

3,205,429

234,818 298,024

1,555,767 3,529,221

7.33% 3.86%

48.54% 45.76%

UMIC

7,711,868

HIC

7,713,280

186,419

3,590,381

2.42% 3.57% 3.93%

46.55% 56.69% 46.66%

Other World

58,424

2,083

33,121

17,970,834

752,247

8,939,150

Table 1

We found significant global disparities in the supply of both radiotherapy and PBT. A majority of world countries (N=154, 83.24%) studied do not have any PTR or active plans to do so in the future. On the contrary, a majority of world countries (N=157, 84.86%) studied have at least one MVM machine( Figure 2A-B). However, there was a significant gap between demand and supply for both PBT (2,541 treatment rooms; 651,113 patients) and radiotherapy (10,006 MVMs; 3,501,991 patients) and this was highest in LIC. Supply meets demand in no country and 23 (15%) of 148 countries studied for PBT and radiotherapy, respectively.The average weighted distance to reach PBT services within and outside countries (coloured in the map)providing PBT was 840km and 1071km, respectively. The average weighted distance continentally was the lowest in Europe, with an average of 220km (range, 55.3km in Belgium to 499 km in Italy). It was the highest in Asia (450km). A detailed map visualising this in more detail is found below.